CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory Distress Syndrome (ARDS) and/or Multiple Organ Dysfunction Syndrome (MODS), including those infected with SARS-CoV-2 (COVID-19).

Biotechnology

CMTx Biotech

Joseph Scaduto

Joann Wilson

James Keane

Christopher Czura

Lorne Golub

Sonny Granger

The founding team at CMTx Biotech has a history of experience in strategy, investments, business development, and real estate. They have also attended some of the top schools in the country for business, including Harvard Business School, Columbia Business School, and the University of Virginia Darden School of Business. This team is well-equipped to handle the many facets of running a successful biotech company.

Founding Team

Board of Directors

Leadership Team

Founding Team

About

Team members

Other teams at CMTx Biotech

Board of Directors

Leadership Team